Literature DB >> 15768393

Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region.

Eric Shink1, Mario Harvey, Monique Tremblay, Bernard Gagné, Pascal Belleau, Catherine Raymond, Michel Labbé, Marie-Pierre Dubé, Ronald G Lafrenière, Nicholas Barden.   

Abstract

Previous results from our genetic analyses using pedigrees from a French Canadian population suggested that the interval delimited by markers D12S86 and D12S378 on chromosome 12 was the most probable genomic region to contain a susceptibility gene for affective disorders. Here we present a more detailed genetic analysis of a 7.7 Mb genomic region located on 12q24.31. This region was saturated with 20 microsatellite markers to refine the candidate region and linkage analysis performed in 41 families from the Saguenay-Lac-St-Jean (SLSJ) region of Quebec. The results of two point parametric analysis using MFLINK supported the presence of a susceptibility locus on chromosome 12q24.31. Association studies with microsatellite markers using a case/control sample from the same population (n = 401) and analyzed with CLUMP revealed significant allelic associations between the bipolar phenotype and markers NBG6 (P = 0.008) and NBG12 (P < 10(-3)). According to these results, we investigated candidate genes in the NBG12 area. We analyzed 32 genes for the presence of polymorphisms in coding sequences and intron/exon junctions and genotyped 22 non-synonymous SNPs in the SLSJ case/control sample. Two uncommon polymorphisms (minor allele frequency < or = 0.03) found in KIAA1595 and FLJ22471 genes, gave P-values below 0.05 with the T1 statistic. Moreover, using haplotype analysis, a nearly significant haplotypic association was observed at the HM74 gene. These results do not give strong support for a role in the susceptibility to bipolar disorder of any of these genes analyzed. However, the significance of rare polymorphisms should be explored by further analyses. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15768393     DOI: 10.1002/ajmg.b.30165

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  5 in total

Review 1.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

2.  Candidate region linkage analysis in twins discordant or concordant for depression symptomatology.

Authors:  L Christiansen; Q Tan; T A Kruse; M McGue; K Christensen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-06-05       Impact factor: 3.568

3.  Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder.

Authors:  Christine L Miller; Peter Murakami; Ingo Ruczinski; Randal G Ross; Melissa Sinkus; Bernadette Sullivan; Sherry Leonard
Journal:  Schizophr Res       Date:  2009-06-06       Impact factor: 4.939

4.  Genome-wide significant linkage of schizophrenia-related neuroanatomical trait to 12q24.

Authors:  Emma Sprooten; Cota Navin Gupta; Emma E M Knowles; D Reese McKay; Samuel R Mathias; Joanne E Curran; Jack W Kent; Melanie A Carless; Marcio A Almeida; Thomas D Dyer; Harald H H Göring; Rene L Olvera; Peter Kochunov; Peter T Fox; Ravi Duggirala; Laura Almasy; Vince D Calhoun; John Blangero; Jessica A Turner; David C Glahn
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-10-05       Impact factor: 3.568

Review 5.  Non-synonymous single nucleotide polymorphisms in the P2X receptor genes: association with diseases, impact on receptor functions and potential use as diagnosis biomarkers.

Authors:  Emily A Caseley; Stephen P Muench; Sebastien Roger; Hong-Ju Mao; Stephen A Baldwin; Lin-Hua Jiang
Journal:  Int J Mol Sci       Date:  2014-07-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.